Figure 4. Power spectral analysis of RR interval of the data shown in Figure 3at baseline (BL; left) and 3 h postoperatively (R3; right). The patient given placebo (A and B) showed a profound postoperative reduction of power across low-frequency (0.00-0.15 Hz) and high-frequency (0.15-0.50 Hz) ranges, consistent with the reduced variability of RR interval observed in Figure 3B. The patient given clonidine (C and D) showed a preservation of power across the high- and low-frequency ranges in the postoperative period, consistent with the large amplitude of RR interval variation observed in Figure 3D.

Figure 4. Power spectral analysis of RR interval of the data shown in Figure 3at baseline (BL; left) and 3 h postoperatively (R3; right). The patient given placebo (A and B) showed a profound postoperative reduction of power across low-frequency (0.00-0.15 Hz) and high-frequency (0.15-0.50 Hz) ranges, consistent with the reduced variability of RR interval observed in Figure 3B. The patient given clonidine (C and D) showed a preservation of power across the high- and low-frequency ranges in the postoperative period, consistent with the large amplitude of RR interval variation observed in Figure 3D.

Close Modal

or Create an Account

Close Modal
Close Modal